Stryker Corporation
Stryker Reports Strong 2023 Results and Outlook for 2024
Summary
Stryker Corporation reported significant financial growth for the fourth quarter and full year of 2023, with net sales increasing by 11.8% in Q4 and 11.1% for the full year. Reported EPS increased by 102.7% in Q4 and 33.7% for the full year. The company also provided an outlook for 2024, expecting organic net sales growth in the range of 7.5% to 9.0% and adjusted net earnings per diluted share between $11.70 and $12.00.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement